Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial
2015-005743-14Phase 3Unknown
- Sponsor
- St George's University Hospitals NHS Foundation Trust
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of digoxin, flecainide and sotalol in atrial flutter (AFL), supraventricular tachycardia (SVT) and Cardiovascular Malformation (CVM) (3 arms), sponsored by St George's University Hospitals NHS Foundation Trust. Primary endpoint: Term delivery of live-born child with normal cardiac rhythm. Status: unknown.
02
Drugs
digoxinflecainidesotalol
03
Conditions
atrial flutter (AFL)supraventricular tachycardia (SVT)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2015-005743-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005743-14.